ILMN - Illumina, Inc. Latest News | Finranks

ILMN - Illumina, Inc. Latest News | Finranks

Here's Why Illumina (ILMN) is a Strong Growth Stock

Here's Why Illumina (ILMN) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

ILMN Stock Gains Following Expanded Collaboration With Labcorp

ILMN Stock Gains Following Expanded Collaboration With Labcorp

Illumina gains after expanding Labcorp collaboration to boost NGS oncology adoption, broaden testing access, and drive growth in precision cancer care.

Illumina and Labcorp expand collaboration to broaden access to precision oncology testing

Illumina and Labcorp expand collaboration to broaden access to precision oncology testing

SAN DIEGO, March 18, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration to advance precision oncology through innovative applications of next-generation sequencing (NGS) solutions across the healthcare ecosystem. Projects are expected to include promoting equitable access to cancer biomarker testing by bringing it closer to patients through new distributed test offerings; generating evidence to facilitate payer coverage; and developing new tests to address areas of unmet need.

Illumina advances preventive genomics through strategic consortium with Veritas Genetics

Illumina advances preventive genomics through strategic consortium with Veritas Genetics

New collaboration aims to bring population-scale whole-genome sequencing into everyday healthcare, enabling earlier risk detection and data-driven prevention SAN DIEGO, March 16, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced a strategic collaboration with Veritas Genetics Powered By Fuze Health to form a consortium that aims to bring preventive genomics into everyday healthcare through health insurance plans in the United States and under other global markets, setting a new standard for proactive health management. By combining clinical-grade sequencing, advanced informatics, and member-ready reporting, the collaboration supports an integrated data ecosystem to advance research, drug discovery, and clinical trial optimization.

Illumina Stock Climbs 44.8% in a Year: What's Driving the Rally?

Illumina Stock Climbs 44.8% in a Year: What's Driving the Rally?

ILMN stock surges 44.8% in a year, fueled by NovaSeq X sequencing demand, broader NGS testing adoption, multiomics expansion and improving margins.

Here's Why Illumina (ILMN) is a Strong Momentum Stock

Here's Why Illumina (ILMN) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Illumina (ILMN) is a Strong Value Stock

Here's Why Illumina (ILMN) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Videos

No Data

There is no data to display